Patent · US Active

Methods and therapies for treating inflammatory conditions with exposed collagen

US9623129B2 · kind B2 · utility

7Cited by

19References

14Claims

0Family size

Assignee

SnIP Holdings, Incorporated · US

Inventors

Gilbert R. Gonzales · New York, US
Dale P. DeVore · Chelmsford, US
Suresh C. Srivastava · Port Jefferson, US

Key dates

Filing date	Sep 25, 2006
Grant date	Apr 18, 2017
Priority date	—
Expiry date	Dec 17, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2121/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions and methods for treating and imaging vulnerable plaque and other inflammatory conditions in a patient rely on the delivery of conversion electron-emitting sources and other radionuclides to regions of exposed collagen in the vasculature or other body lumens. The conversion electron-emitting sources or other radionuclides are coupled to a collagen-binding substance and administered to the vasculature or other body lumen to permit binding for imaging and/or therapeutic purposes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.